Month: <span>July 2020</span>

Home / 2020 / July
Post

Why Is Full-Spectrum CBD Better Than Hemp CBD or CBD Isolate?

This article was originally published on Blue Ribbon Hemp. To view the original article, click here. Cannabidiol (CBD) is a popular treatment for ailments like chronic pain, Parkinson’s disease, anxiety, Crohn’s disease, and gastrointestinal issues. If you have decided to buy CBD online, you have probably noticed that there are options like full-spectrum CBD and...

Daily coffee may lower risk for developing arrhythmia
Post

Daily coffee may lower risk for developing arrhythmia

Regular coffee consumption is associated with a significantly lower risk for arrhythmias, according to a study presented recently as part of the Heart Rhythm Society online meeting: HRS 2020 Science. Eun-Jeong Kim, M.D., from the University of California in San Francisco, and colleagues investigated the association between habitual caffeine consumption and the risk for arrhythmia...

Breakthrough discovery to transform prostate cancer treatment
Post

Breakthrough discovery to transform prostate cancer treatment

A NOVEL FORMULATION OF THE PROSTATE CANCER DRUG ABIRATERONE ACETATE – CURRENTLY MARKETED AS ZYTIGA – WILL DRAMATICALLY IMPROVE THE QUALITY OF LIFE FOR PEOPLE SUFFERING FROM PROSTATE CANCER.view more CREDIT: HAYLEY SCHULTZ/UNISA A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of...

Shining light on a malignant lung cancer
Post

Shining light on a malignant lung cancer

A near-infrared light treatment could help manage a rare form of lung cancer THE THERAPY COULD INVOLVE INJECTING A PODOPLANIN ANTIBODY CONJUGATED WITH A PHOTOABSORBER AND THEN SHINING NEAR-INFRARED LIGHT INTO THE CHEST CAVITY. Treating a rare type of malignant lung cancer could improve, thanks to near-infrared irradiation and a cancer-targeting compound. Nagoya University oncologist...

Post

New adjuvant successful in extending immunity against HIV

ATLANTA – Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today in Science Immunology. In this pre-clinical study that included 90 rhesus monkeys, the researchers showed 3M-052, a new, synthetic...

Post

The New JAK inhibitor Upadacitinib (Rinvoq) Shows Promise for Psoriatic Arthritis

Approved in 2019 for moderate to severe rheumatoid arthritis, the drug may offer an oral alternative to infused or injected biologics. The JAK inhibitor upadacitinib (Rinvoq) became a treatment option in 2019 for people with rheumatoid arthritis(RA) who had not responded well to methotrexate, the disease-modifying anti-rheumatic drug (DMARD) that is the first-line treatment for...

Post

Targeting stem cells: The path to curing poor-prognosis leukaemia

Researchers at Children’s Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML Researchers at Children’s Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML. Unlike acute lymphoblastic...

Research finds balance tests key in better gauging concussions
Post

Research finds balance tests key in better gauging concussions

by Florida Institute of Technology As professional football approaches the July start of training camps and prep and college football programs look toward their fall seasons, new research from Florida Tech into concussions among student-athletes may have found a better way to understand the severity of these head injuries: balance tests. In “Change in Balance...